30 сент. 2024 г. · Bristol Myers Squibb (BMY.N) won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval.

14 нояб. 2024 г. · Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal ...

In March 2003, Bristol-Myers restated its prior financial statements and disclosed its channel-stuffing activities and improper accounting. Simultaneous with ...

During 2000 to 2001, defendant BRISTOL-MYERS SQUIBB COMPANY and its co- conspirators regularly used financial incentives to spur wholesalers to buy product in ...

14 нояб. 2024 г. · Bristol Myers Squibb (BMY) was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for ...

The whistleblower lawsuit alleged that Bristol-Myers Squibb violated the California Insurance Frauds Prevention Act by employing and using sales representatives ...

15 нояб. 2024 г. · Bristol Myers Squibb on Thursday was hit with a $6.7 billion lawsuit from former shareholders of Celgene alleging that the pharma took steps to avoid paying ...

During the 2000s, the company faced accusations of deceptive advertising campaigns and FDA violations. BMS has also had to deal with litigation related to two ... History · Investigations · Problematic Products · Plavix

16 окт. 2024 г. · An SEC investigation could be good news for employees who have witnessed bribery or corruption at Bristol-Myers Squibb and have the courage to ...

Also in 2002, Bristol-Myers Squibb was involved in an accounting scandal that resulted in a significant restatement of revenues from 1999 to 2001. History · Finances · Public-private engagement